Prelude Capital Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 17,703 shares of VNDA stock, worth $88,160. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,703

Previous 17,703 -0.0%

Holding current value

$88,160

Previous $83,000 -0.0%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.61 - $6.34 $461 - $634	100 Added 0.57%	17,703 $83,000
Q2 2024 Aug 14, 2024	SELL	$3.91 - $6.5 $83,271 - $138,430	-21,297 Reduced 54.75%	17,603 $99,000
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $4,164 - $5,532	-1,200 Reduced 2.99%	38,900 $159,000
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $6,611 - $8,958	-1,956 Reduced 4.65%	40,100 $169,000
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $9,826 - $15,084	2,296 Added 5.77%	42,056 $181,000
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $69,183 - $81,495	11,726 Added 41.83%	39,760 $262,000
Q1 2023 May 15, 2023	BUY	$6.18 - $7.99 $26,314 - $34,021	4,258 Added 17.91%	28,034 $190,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $163,341 - $260,584	23,776 New	23,776 $175,000
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $47,228 - $66,757	-4,834 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $24,865 - $32,069	-2,668 Reduced 35.56%	4,834 $47,000
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $9,660 - $12,020	1,000 Added 15.38%	7,502 $86,000
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $18,067 - $40,471	2,409 Added 58.86%	6,502 $67,000
Q4 2019 Feb 14, 2020	BUY	$12.38 - $17.47 $43,986 - $62,070	3,553 Added 657.96%	4,093 $67,000
Q3 2019 Nov 14, 2019	SELL	$12.27 - $15.79 $4,981 - $6,410	-406 Reduced 42.92%	540 $7,000
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $10,535 - $14,853	-788 Reduced 45.44%	946 $13,000
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $773 - $1,366	44 Added 2.6%	1,734 $32,000
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $14,549 - $24,137	767 Added 83.1%	1,690 $44,000
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $39,255 - $49,473	-2,151 Reduced 69.97%	923 $21,000
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $68,382 - $93,873	-4,902 Reduced 61.46%	3,074 $59,000
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $98,715 - $141,925	7,026 Added 739.58%	7,976 $134,000
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $7,363 - $10,371	-573 Reduced 37.62%	950 $14,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $23,454 - $28,708	1,523	1,523 $27,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $282M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Vanda Pharmaceuticals Inc. Transaction History